$MED
MEDIFAST INC Stock $med

$med Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000114420414048498 Filed on August 11, 2014

Income Statement

Concept	2014 Q2	2013 Q4	2013 Q2
Revenue	$74.73M	$70.30M	$97.07M
YoY Change	-23.01%	-15.5%	3.74%
Cost Of Revenue	$19.16M	$18.30M	$24.14M
YoY Change	-20.64%	-10.29%	3.03%
Gross Profit	$55.57M	$51.90M	$72.93M
YoY Change	-23.8%	-17.36%	3.98%
Gross Profit Margin	74.36%	73.83%	75.13%
Selling, General & Admin	$45.71M	$41.90M	$62.29M
YoY Change	-26.61%	-28.98%	-4.96%
% of Gross Profit	82.26%	80.73%	85.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.542M	$0.00	$2.590M
YoY Change	-1.85%	-100.0%	-7.76%
% of Gross Profit	4.57%	0.0%	3.55%
Operating Expenses	$45.71M	$41.90M	$62.29M
YoY Change	-26.61%	-29.22%	-4.96%
Operating Profit	$9.861M	$10.00M	$10.64M
YoY Change	-7.33%	177.78%	131.43%
Interest Expense	$170.0K	$200.0K	$98.00K
YoY Change	73.47%	100.0%	8.89%
% of Operating Profit	1.72%	2.0%	0.92%
Other Income/Expense, Net	$233.0K	-$500.0K	$237.0K
YoY Change	-1.69%		-73.78%
Pretax Income	$8.685M	$9.800M	$10.88M
YoY Change	-20.16%	172.22%	97.71%
Income Tax	$3.475M	$2.600M	$3.805M
% Of Pretax Income	40.01%	26.53%	34.98%
Net Earnings	$5.720M	$5.300M	$7.073M
YoY Change	-19.13%	178.95%	151.44%
Net Earnings / Revenue	7.65%	7.54%	7.29%
Basic Earnings Per Share	$0.44		$0.51
Diluted Earnings Per Share	$0.44	$389.7K	$0.51
COMMON SHARES
Basic Shares Outstanding	13.05M shares	13.88M shares	13.86M shares
Diluted Shares Outstanding	13.15M shares		13.96M shares

Balance Sheet

Concept	2014 Q2	2013 Q4	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.6M	$104.2M	$122.5M
YoY Change	-17.9%	4.26%	116.46%
Cash & Equivalents	$32.02M	$36.38M	$44.41M
Short-Term Investments	$68.57M	$67.80M	$78.11M
Other Short-Term Assets	$4.500M	$5.600M	$4.800M
YoY Change	-6.25%	16.67%	26.32%
Inventory	$17.58M	$17.54M	$15.98M
Prepaid Expenses
Receivables	$1.693M	$942.0K	$1.965M
Other Receivables	$0.00	$0.00	$300.0K
Total Short-Term Assets	$92.26M	$91.95M	$101.2M
YoY Change	-8.83%	3.81%	27.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.08M	$34.48M	$40.67M
YoY Change	-8.82%	-14.04%	2.63%
Goodwill
YoY Change
Intangibles		$0.00	$167.0K
YoY Change		-100.0%	-77.46%
Long-Term Investments
YoY Change
Other Assets	$400.0K	$231.0K	$419.0K
YoY Change	-4.53%	-79.72%	-61.77%
Total Long-Term Assets	$37.48M	$40.70M	$41.25M
YoY Change	-9.14%	-2.35%	-0.5%
TOTAL ASSETS
Total Short-Term Assets	$92.26M	$91.95M	$101.2M
Total Long-Term Assets	$37.48M	$40.70M	$41.25M
Total Assets	$129.7M	$132.7M	$142.4M
YoY Change	-8.92%	1.84%	17.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.20M	$12.00M	$30.70M
YoY Change	-17.92%	-57.45%	1.99%
Accrued Expenses		$4.800M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$0.00	$200.0K
YoY Change	0.0%	-100.0%	-66.67%
Total Short-Term Liabilities	$26.01M	$27.10M	$30.93M
YoY Change	-15.9%	-5.73%	0.95%
LONG-TERM LIABILITIES
Long-Term Debt	$400.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$400.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.01M	$27.10M	$30.93M
Total Long-Term Liabilities	$400.0K	$0.00	$0.00
Total Liabilities	$32.23M	$34.23M	$37.89M
YoY Change	-14.95%	-13.25%	-8.83%
SHAREHOLDERS EQUITY
Retained Earnings	$109.4M	$97.70M	$89.54M
YoY Change	22.17%	27.66%	32.73%
Common Stock	$13.00K	$13.00K	$16.00K
YoY Change	-18.75%	-18.75%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.23M	$0.00	$26.51M
YoY Change	-46.33%	-100.0%	0.0%
Treasury Stock Shares	451.0K shares	0.000 shares	1.609M shares
Shareholders Equity	$97.51M	$98.42M	$104.5M
YoY Change
Total Liabilities & Shareholders Equity	$129.7M	$132.7M	$142.4M
YoY Change	-8.92%	1.84%	17.76%

Cashflow Statement

Concept	2014 Q2	2013 Q4	2013 Q2
OPERATING ACTIVITIES
Net Income	$5.720M	$5.300M	$7.073M
YoY Change	-19.13%	178.95%	151.44%
Depreciation, Depletion And Amortization	$2.542M	$0.00	$2.590M
YoY Change	-1.85%	-100.0%	-7.76%
Cash From Operating Activities	$5.700M	$8.300M	$12.90M
YoY Change	-55.81%	1283.33%	20.56%
INVESTING ACTIVITIES
Capital Expenditures	-$1.700M	-$2.800M	-$3.100M
YoY Change	-45.16%	300.0%	10.71%
Acquisitions
YoY Change
Other Investing Activities	$1.000M	$3.000M	-$14.80M
YoY Change	-106.76%	-178.95%	-3060.0%
Cash From Investing Activities	-$800.0K	$200.0K	-$17.80M
YoY Change	-95.51%	-104.35%	673.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.30M	-20.10M	0.000
YoY Change		-3450.0%	-100.0%
NET CHANGE
Cash From Operating Activities	5.700M	8.300M	12.90M
Cash From Investing Activities	-800.0K	200.0K	-17.80M
Cash From Financing Activities	-14.30M	-20.10M	0.000
Net Change In Cash	-9.400M	-11.60M	-4.900M
YoY Change	91.84%	241.18%	-194.23%
FREE CASH FLOW
Cash From Operating Activities	$5.700M	$8.300M	$12.90M
Capital Expenditures	-$1.700M	-$2.800M	-$3.100M
Free Cash Flow	$7.400M	$11.10M	$16.00M
YoY Change	-53.75%	753.85%	18.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	us-gaap	Assets Assets	129736000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	91954000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2890000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1957000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40336000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	360000	USD
CY2013Q4	us-gaap	Assets Assets	132650000	USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	36552000	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2351000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2062000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	92256000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37080000	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	17579000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	18059000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	31420000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	400000	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	26780000	USD
CY2014Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	575000	USD
CY2014Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	227000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26011000	USD
CY2014Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	359000	USD
CY2014Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5859000	USD
CY2014Q2	us-gaap	Liabilities Liabilities	32229000	USD
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2013Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	99000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36382000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1246000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	222000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27101000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	474000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	6659000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	34234000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	887000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	109387000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	97507000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	129736000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13050346	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13111348	shares
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32019000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1693000	USD
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	25209000	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1446000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	703000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	97700000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	98416000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132650000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.89
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13149414	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2014Q2	us-gaap	Retail Related Inventory RetailRelatedInventory	795000	USD
CY2014Q2	med	Inventory Non Food Finished Goods InventoryNonFoodFinishedGoods	939000	USD
CY2014Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11910000	USD
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13006000	USD
	us-gaap	Net Income Loss NetIncomeLoss	11687000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	7073000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13836087	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13863043	shares
	med	Effect Of Dilutive Common Stock Equivalent EffectOfDilutiveCommonStockEquivalent	159084	shares
	med	Effect Of Dilutive Common Stock Equivalent EffectOfDilutiveCommonStockEquivalent	88859	shares
CY2013Q2	med	Effect Of Dilutive Common Stock Equivalent EffectOfDilutiveCommonStockEquivalent	100014	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13995171	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13200207	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13963057	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	70542	shares
CY2014Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4085000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5381000	USD
CY2013Q4	us-gaap	Retail Related Inventory RetailRelatedInventory	757000	USD
CY2013Q4	med	Inventory Non Food Finished Goods InventoryNonFoodFinishedGoods	855000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11356000	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	290000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	5720000	USD
CY2014Q2	med	Effect Of Dilutive Common Stock Equivalent EffectOfDilutiveCommonStockEquivalent	99068	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	70542	shares
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	66960000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	66514000	USD
CY2014Q2	us-gaap	Interest Receivable InterestReceivable	123000	USD
CY2013Q4	us-gaap	Interest Receivable InterestReceivable	109000	USD
CY2014Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	68571000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	67802000	USD
CY2014Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	36552000	USD
CY2013Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	31420000	USD
CY2014Q2	med	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	547000	USD
CY2013Q4	med	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	647000	USD
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1500000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1500000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13176018	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13143309	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12718351	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13115642	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0161	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6315	pure
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	237000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y4M28D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y8M1D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	303376	USD
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	29294	USD
CY2014Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	900000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	20523000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70542	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70542	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5051	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	26.11
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.11
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.61
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.19
	us-gaap	Revenues Revenues	193115000	USD
	us-gaap	Revenues Revenues	167412000	USD
CY2013Q2	us-gaap	Revenues Revenues	97072000	USD
CY2014Q2	us-gaap	Revenues Revenues	80883000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	47776000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	43118000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	24142000	USD
	med	Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization	120899000	USD
	med	Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization	103109000	USD
CY2013Q2	med	Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization	59699000	USD
CY2014Q2	med	Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization	50406000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5221000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5077000	USD
CY2013Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2590000	USD
CY2014Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2542000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	369000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1583000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1273000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19588000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	17691000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	10878000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8685000	USD
CY2013Q2	us-gaap	Assets Assets	142441000	USD
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	270000000	USD
	us-gaap	Gross Profit GrossProfit	145339000	USD
	us-gaap	Gross Profit GrossProfit	124294000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	72930000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	60360000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126120000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	108186000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62289000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	52948000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	19219000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	16108000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	10641000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	7412000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	150000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	296000	USD
CY2013Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	98000	USD
CY2014Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	170000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	219000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1287000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1103000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6582000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6004000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3805000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2965000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-308000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	317000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-412000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	214000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	185000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	133000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1151000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1407000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-552000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1030000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	32000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	122000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	42000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-493000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	184000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-534000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	172000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-493000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	184000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-534000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	172000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12513000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11871000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6539000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5892000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1407000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	198000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	233000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-61000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-183000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	447000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4823000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-480000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-314000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-539000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-708000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	55000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2461000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1571000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	539000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	476000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	27717000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16298000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	5909000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	6426000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	20187000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	11016000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5577000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3004000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-19855000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6379000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3504000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	110000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	12000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	15000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-3394000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-14282000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4468000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4363000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39937000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44405000	USD
	us-gaap	Interest Paid InterestPaid	38000	USD
	us-gaap	Interest Paid InterestPaid	93000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	6418000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	6499000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div style="CLEAR:both;CLEAR: both">1.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Basis of Presentation</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The condensed unaudited interim consolidated financial statements included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included. The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">   </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The results of operations for the three months and six months ended June 30, 2014 are not necessarily indicative of results that may be expected for the year ending December 31, 2014. The accompanying condensed unaudited interim consolidated financial statements should be read in conjunction with the 2013 audited financial statements and notes thereto, which are included in the Company’s Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2013 (“2013 Form 10-K”), which should be read in conjunction with these consolidated financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	MEDIFAST INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000910329
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	MED
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12739149	shares
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	14226000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	39000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	14226000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	98000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	39000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14226000	USD
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	451000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2014Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1619000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1442000	USD
CY2014Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	-131000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	-263000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1215000	USD

Files In Submission

Name	View Source	Status
0001144204-14-048498-index-headers.html	Edgar Link	pending
0001144204-14-048498-index.html	Edgar Link	pending
0001144204-14-048498.txt	Edgar Link	pending
0001144204-14-048498-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
med-20140630.xml	Edgar Link	completed
med-20140630.xsd	Edgar Link	pending
med-20140630_cal.xml	Edgar Link	unprocessable
med-20140630_def.xml	Edgar Link	unprocessable
med-20140630_lab.xml	Edgar Link	unprocessable
med-20140630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v384919_10q.htm	Edgar Link	pending
v384919_ex31-1.htm	Edgar Link	pending
v384919_ex31-2.htm	Edgar Link	pending
v384919_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MED
MEDIFAST INC Stock $med

2014 Q2 Form 10-Q Financial Statement

#000114420414048498 Filed on August 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MED MEDIFAST INC Stock $med

2014 Q2 Form 10-Q Financial Statement

#000114420414048498 Filed on August 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MED
MEDIFAST INC Stock $med